Literature DB >> 15691017

Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition.

Alice J Owen1, Beata A Peter-Przyborowska, Andrew J Hoy, Peter L McLennan.   

Abstract

Fish consumption is associated with reduced cardiovascular mortality, and elevated myocardial long-chain n-3 polyunsaturated FA (PUFA) content is implicated in this cardioprotection. This study examined the dose and time responses for incorporation of n-3 PUFA into cellular membranes in rats fed fish oil (FO)-containing diets. For the time course study, rats were fed a 10% FO diet for periods ranging from 0 to 42 d, after which myocardial and erythrocyte membrane fatty acid composition was determined. For the dose response study, rats (n = 3) were fed 0, 1.25, 2.5, 5, or 10% FO for 4 wk, with myocardial, erythrocyte, and skeletal muscle membrane FA determined. Myocardial DHA (22:6n-3) levels doubled in 2 d, stabilizing at levels approximately 200% higher than control after 28 d feeding with 10% FO. By comparison, DHA levels doubled after 4 wk of 1.25% FO feeding. In myocardium and skeletal muscle, EPA (20:5n-3) levels remained low, but in erythrocytes EPA levels reached 50% of DHA levels. The n-3 PUFA were incorporated at the expense of n-6 PUFA in myocardium and skeletal muscle, whereas erythrocytes maintained arachidonic acid levels, and total n-3 PUFA incorporation was lower. This study shows that low doses of FO produce marked changes in myocardial DHA levels; maximal incorporation takes up to 28 d to occur; and while erythrocytes are a good indicator of tissue n-3 incorporation in stable diets, they vary greatly in their time course and pattern of incorporation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15691017     DOI: 10.1007/s11745-004-1317-0

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

1.  A hypothesis on the development of acute myocardial infarction in Greenlanders.

Authors:  J Dyerberg; H O Bang
Journal:  Scand J Clin Lab Invest Suppl       Date:  1982

2.  The relationship between linoleic acid level in serum, adipose tissue and myocardium in humans.

Authors:  P T Sexton; A J Sinclair; K O'Dea; A J Sanigorski; J Walsh
Journal:  Asia Pac J Clin Nutr       Date:  1995-09       Impact factor: 1.662

3.  Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.

Authors:  C von Schacky; P C Weber
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

4.  Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues.

Authors:  G Calviello; P Palozza; P Franceschelli; G M Bartoli
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

5.  Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

6.  Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.

Authors:  William S Harris; Scott A Sands; Sheryl L Windsor; Hakim A Ali; Tracy L Stevens; Anthony Magalski; Charles B Porter; A Michael Borkon
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

7.  Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method.

Authors:  M J Derelanko
Journal:  Fundam Appl Toxicol       Date:  1987-08

8.  Differences in fatty acid composition of various tissues of the marmoset monkey (Callithrix jacchus) after different lipid supplemented diets.

Authors:  J S Charnock; M Y Abeywardena; V M Poletti; P L McLennan
Journal:  Comp Biochem Physiol Comp Physiol       Date:  1992-02

9.  Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.

Authors:  Luigi Tavazzi; Gianni Tognoni; Maria Grazia Franzosi; Roberto Latini; Aldo Pietro Maggioni; Roberto Marchioli; Gian Luigi Nicolosi; Maurizio Porcu
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534

10.  Membrane lipids and sodium pumps of cattle and crocodiles: an experimental test of the membrane pacemaker theory of metabolism.

Authors:  B J Wu; A J Hulbert; L H Storlien; P L Else
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09       Impact factor: 3.619

View more
  31 in total

Review 1.  Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease.

Authors:  Ning Li; Jun-Yan Liu; Hong Qiu; Todd R Harris; Padmini Sirish; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Congest Heart Fail       Date:  2011-01-27

2.  Dietary fish oil dose-response effects on ileal phospholipid fatty acids and contractility.

Authors:  Glen S Patten; Michael J Adams; Julie A Dallimore; Mahinda Y Abeywardena
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

3.  Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice.

Authors:  Natalie D Riediger; Rgia Othman; Evelyn Fitz; Grant N Pierce; Miyoung Suh; Mohammed H Moghadasian
Journal:  Eur J Nutr       Date:  2008-05-03       Impact factor: 5.614

Review 4.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

5.  Influencing mitochondrial membrane composition and bioenergetics through omega-3 supplementation.

Authors:  Stewart Jeromson; David J Hunter
Journal:  J Physiol       Date:  2014-05-01       Impact factor: 5.182

6.  Polyunsaturated fatty acids in relation to incident mobility disability and decline in gait speed; the Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  I Reinders; R A Murphy; X Song; M Visser; M F Cotch; T F Lang; M E Garcia; L J Launer; K Siggeirsdottir; G Eiriksdottir; P V Jonsson; V Gudnason; T B Harris; I A Brouwer
Journal:  Eur J Clin Nutr       Date:  2015-01-14       Impact factor: 4.016

7.  Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats.

Authors:  Emily L Slee; Peter L McLennan; Alice J Owen; Mandy L Theiss
Journal:  J Lipid Res       Date:  2010-03-10       Impact factor: 5.922

8.  Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters.

Authors:  Roberta Fiaccavento; Felicia Carotenuto; Marilena Minieri; Laura Masuelli; Alba Vecchini; Roberto Bei; Andrea Modesti; Luciano Binaglia; Angelo Fusco; Aldo Bertoli; Giancarlo Forte; Luciana Carosella; Paolo Di Nardo
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

9.  Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle.

Authors:  E A F Herbst; S Paglialunga; C Gerling; J Whitfield; K Mukai; A Chabowski; G J F Heigenhauser; L L Spriet; G P Holloway
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

10.  Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Trent L Gaugler; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-17       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.